Referrals for Patients with Polycythemia VeraVideo Categories: Polycythemia Vera
Supported through funding from Incyte
Drs. David Rimm and Roy Herbst review the problems with the CMS â14-Day Ruleâ since some of the multigene panel biomarker tests require 21 days or longer to complete.
Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.